These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9885798)

  • 1. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression.
    Maes M; Lin AH; Verkerk R; Delmeire L; Van Gastel A; Van der Planken M; Scharpé S
    Neuropsychopharmacology; 1999 Feb; 20(2):188-97. PubMed ID: 9885798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder.
    Croonenberghs J; Delmeire L; Verkerk R; Lin AH; Meskal A; Neels H; Van der Planken M; Scharpe S; Deboutte D; Pison G; Maes M
    Neuropsychopharmacology; 2000 Mar; 22(3):275-83. PubMed ID: 10693155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients.
    Arora RC; Fichtner CG; O'Connor F; Crayton JW
    Life Sci; 1993; 53(11):919-28. PubMed ID: 8366759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia.
    Maes M; Verkerk R; Delmeire L; Van Gastel A; van Hunsel F; Scharpé S
    Psychiatry Res; 2000 Dec; 97(1):11-20. PubMed ID: 11104853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
    Maes M; Van Gastel A; Delmeire L; Meltzer HY
    Biol Psychiatry; 1999 Feb; 45(3):278-84. PubMed ID: 10023502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
    Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
    Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet paroxetine binding in post-traumatic stress disorder.
    Maguire K; Norman T; Burrows G; Hopwood M; Morris P
    Psychiatry Res; 1998 Jan; 77(1):1-7. PubMed ID: 10710169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
    Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
    Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders.
    Ramacciotti CE; Coli E; Paoli R; Marazziti D; Dell'Osso L
    Psychiatry Res; 2003 May; 118(1):33-8. PubMed ID: 12759159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonergic markers in posttraumatic stress disorder.
    Pivac N; Mück-Seler D; Sagud M; Jakovljević M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1193-8. PubMed ID: 12452545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response.
    Fichtner CG; Arora RC; O'Connor FL; Crayton JW
    Life Sci; 1994; 54(3):PL39-44. PubMed ID: 8289574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.